Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024885
Filing Date
2024-10-08
Accepted
2024-10-08 16:40:31
Documents
1
Period of Report
2024-10-04

Document Format Files

Seq Description Document Type Size
1 form4-10082024_081027.html 4  
1 form4-10082024_081027.xml 4 7102
  Complete submission text file 0001415889-24-024885.txt   8610
Mailing Address 1050 HINGHAM STREET ROCKLAND MA 02370
Business Address
Megna Michael R (Reporting) CIK: 0001464583 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38492 | Film No.: 241360743

Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Issuer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)